Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 163 results for "zydus group cadila healthcare"

Zydus gets tentative nod from USFDA to market diabetic tablets
India TV

Zydus gets USFDA nod to market anti-diabetic tablets; closes d...

Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ... India Infoline, 4 days ago
Zydus gets USFDA tentative nod for diabetic tablets Press Trust of India, 5 days ago
[x]  

Zydus gets Gilead licence for Hepatitis C treatment

Cadila Healthcare Ltd (Zydus Cadila) on Monday said it has been granted generic licence by Gilead Sciences Inc, to manufacture breakthrough treatment of Hepatitis C. The two companies have entered into a generic, non-exclusive licensing agreement ...
 Hindu Business Line5 days ago Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C  Equity Bulls4 days ago Zydus granted license to produce generic hepatitis C drug  Smart Investor5 days ago

India : TENTATIVE Approval for Glipizide ER Tablets received by Zydus [TendersInfo (India)]

Cadila Healthcare Ltd. said that it had obtained tentative approval from the US FDA o market Glipizide Extended-release tablets in the strengths of 2.5 mg, 5 mg and 10 mg. The drug falls in the anti-diabetic segment. As per IMS data the estimates ...
 Pharmacy Choice3 days ago Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets  Indian-Commodity5 days ago
Business Standard India

Zydus Cadila bags license for hepatitis C drug

medabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment of ...
 Business Standard India5 days ago

Cadila Healthcare jumps after USFDA OK for anti-viral drug

Cadila Healthcare rose 3.67% to Rs 1,235.70 at 12:50 IST on BSE after the company said Zydus Cadila has received the final approval from the US drug regulator to sell anti-viral drug in multiple strengths in the US market. The company made the ...
 Capital Market1 month ago

Stocks in news: Maruti, JSPL, Wockhardt, Bharti, Cadila

Q1FY15 GDP at 5.7 percent versus 4.7 percent (YoY) -Q1FY15 GDP at 5.7 percent versus 4.6 percent (QoQ) Alert: Q1FY15 GDP at 5.7 percent, highest since Q4FY12 -Agri sector growth at 3.8 percent versus 4 percent (YoY)-Agri sector growth at 3.8 ...
 Moneycontrol.com2 weeks ago

SBL rebrands as Sunshine Healthcare Lanka

A leading listed diversified conglomerate, Sunshine Holdings PLC, rebranded one of their subsidiaries with the intention of positioning the group as a key player in the healthcare segment. The move, which has been planned for well over an year ...
 Sri Lanka Daily News1 month ago

Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines

FEATURED COMPANIES Aurobindo Pharma Cipla Dr Reddy's Laboratories Mankind Pharma Piramal Group Reliance Life Sciences MORE PHARMACEUTICAL MARKET INDIA 2014-2020, ...
 Research and Markets2 months ago Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles  Individual.com1 week ago Research and Markets: Renal Anemia - Pipeline Review, H2 2014 - 22 Companies & 25 Drug Profiles  TMC Net1 week ago India Pharmaceutical Market 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines  Individual.com2 months ago
[x]  

Global Markets for Generic Drugs

LONDON , Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: https://www.reportbuyer.com/product/2009161/Global-Markets-for-Generic-Drugs.html STUDY GOALS AND OBJECTIVES The aim of this report is to provide ...
 Wall Street Business Network2 weeks ago
[x]  

Daily Market Strategy - Indices could swing at new highs!

Behind me is infinite power, before me is endless possibility, around me is boundless opportunity. Anonymous The market appears to be in good cheer after a break even as the rain Gods are showering abundantly in Mumbai and its adjoining areas.
 India Infoline2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less